Style | Citing Format |
---|---|
MLA | Najafi Z, et al.. "Proteomic and Genomic Biomarkers for Non-Small Cell Lung Cancer: Peroxiredoxin, Haptoglobin, and Alpha-1 Antitrypsin." Cancer Medicine, vol. 9, no. 11, 2020, pp. 3974-3982. |
APA | Najafi Z, Mohamadnia A, Ahmadi R, Mahmoudi M, Bahrami N, Khosravi A, Jamaati H, Tabarsi P, Kazem Pour Dizaji M, Shirian S (2020). Proteomic and Genomic Biomarkers for Non-Small Cell Lung Cancer: Peroxiredoxin, Haptoglobin, and Alpha-1 Antitrypsin. Cancer Medicine, 9(11), 3974-3982. |
Chicago | Najafi Z, Mohamadnia A, Ahmadi R, Mahmoudi M, Bahrami N, Khosravi A, Jamaati H, Tabarsi P, Kazem Pour Dizaji M, Shirian S. "Proteomic and Genomic Biomarkers for Non-Small Cell Lung Cancer: Peroxiredoxin, Haptoglobin, and Alpha-1 Antitrypsin." Cancer Medicine 9, no. 11 (2020): 3974-3982. |
Harvard | Najafi Z et al. (2020) 'Proteomic and Genomic Biomarkers for Non-Small Cell Lung Cancer: Peroxiredoxin, Haptoglobin, and Alpha-1 Antitrypsin', Cancer Medicine, 9(11), pp. 3974-3982. |
Vancouver | Najafi Z, Mohamadnia A, Ahmadi R, Mahmoudi M, Bahrami N, Khosravi A, et al.. Proteomic and Genomic Biomarkers for Non-Small Cell Lung Cancer: Peroxiredoxin, Haptoglobin, and Alpha-1 Antitrypsin. Cancer Medicine. 2020;9(11):3974-3982. |
BibTex | @article{ author = {Najafi Z and Mohamadnia A and Ahmadi R and Mahmoudi M and Bahrami N and Khosravi A and Jamaati H and Tabarsi P and Kazem Pour Dizaji M and Shirian S}, title = {Proteomic and Genomic Biomarkers for Non-Small Cell Lung Cancer: Peroxiredoxin, Haptoglobin, and Alpha-1 Antitrypsin}, journal = {Cancer Medicine}, volume = {9}, number = {11}, pages = {3974-3982}, year = {2020} } |
RIS | TY - JOUR AU - Najafi Z AU - Mohamadnia A AU - Ahmadi R AU - Mahmoudi M AU - Bahrami N AU - Khosravi A AU - Jamaati H AU - Tabarsi P AU - Kazem Pour Dizaji M AU - Shirian S TI - Proteomic and Genomic Biomarkers for Non-Small Cell Lung Cancer: Peroxiredoxin, Haptoglobin, and Alpha-1 Antitrypsin JO - Cancer Medicine VL - 9 IS - 11 SP - 3974 EP - 3982 PY - 2020 ER - |